Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
Esophageal cancer (EC) remains a public health concern with a high mortality and disease burden worldwide. Esophageal squamous cell carcinoma (ESCC) is a predominant histological subtype of EC that has unique etiology, molecular profiles, and clinicopathological features. Although systemic chemother...
Main Authors: | Akira Ooki, Hiroki Osumi, Keisho Chin, Masayuki Watanabe, Kensei Yamaguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359221138377 |
Similar Items
-
Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on <i>RAS</i> Mutation
by: Shohei Udagawa, et al.
Published: (2023-02-01) -
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors
by: Koshiro Fukuda, et al.
Published: (2023-07-01) -
Current Topics in Esophageal Squamous Cell Carcinoma
by: Hiroki Kurumi, et al.
Published: (2020-10-01) -
Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy
by: Xiaojuan Zhao, et al.
Published: (2021-08-01) -
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer
by: Hiroki Osumi, et al.
Published: (2020-06-01)